{"DataElement":{"publicId":"2187731","version":"2","preferredName":"Adverse Event Therapeutic Procedure End Type","preferredDefinition":"the type of adverse event that lead to a discontinuation of treatment.","longName":"AE_END_TX_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2179888","version":"2","preferredName":"Adverse Event Therapeutic Procedure","preferredDefinition":"the adverse event related to a particular treatment modality or to the patient's disease._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","longName":"AE_TX","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2184272","version":"1","preferredName":"Adverse Event","preferredDefinition":"An unwanted effect caused by a drug or therapy.  Such effects can be drug related, dose related, route related, patient related, caused by an interaction with another drug, or caused by opioid initiation or dose escalation.","longName":"Adverse Event","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-194E-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":"Change concept code to C41331 as C2861 is retired per EVS. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2554155","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"249AD8D2-9892-0146-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-12-14","endDate":null,"createdBy":"UMLLOADER_TUMOR","dateCreated":"2006-12-14","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E8B070E-4E76-07AB-E053-F662850A7456","latestVersionIndicator":"Yes","beginDate":"2018-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2018-06-13","modifiedBy":"HARTLEYG","dateModified":"2018-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2187730","version":"1","preferredName":"Adverse Event End Treatment Type","preferredDefinition":"the type of adverse event that lead to a discontinuation of treatment.","longName":"AE_END_TX_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Grade 4 Acute infusion reaction or Allergic reaction/hypersensitivity","valueDescription":"Grade 4 Acute infusion reaction or Allergic reaction/hypersensitivity","ValueMeaning":{"publicId":"2571518","version":"1","preferredName":"Grade 4 Acute infusion reaction or Allergic reaction/hypersensitivity","longName":"2571518","preferredDefinition":"Grade 4 Acute infusion reaction or Allergic reaction/hypersensitivity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E46B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B79B8-7A18-114A-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 3 or 4 Hemorrhage","valueDescription":"Grade 3 or 4 Hemorrhage","ValueMeaning":{"publicId":"2571519","version":"1","preferredName":"Grade 3 or 4 Hemorrhage","longName":"2571519","preferredDefinition":"Grade 3 or 4 Hemorrhage","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E46C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B79B8-7A1C-114A-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 Visceral or peripheral arterial ischemia","valueDescription":"Grade 2, 3, or 4 Visceral or peripheral arterial ischemia","ValueMeaning":{"publicId":"2571521","version":"1","preferredName":"Grade 2, 3, or 4 Visceral or peripheral arterial ischemia","longName":"2571521","preferredDefinition":"Grade 2, 3, or 4 Visceral or peripheral arterial ischemia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E46E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B79B8-7A24-114A-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 Cardiac ischemia/infarction","valueDescription":"Grade 2, 3, or 4 Cardiac ischemia/infarction","ValueMeaning":{"publicId":"2571522","version":"1","preferredName":"Grade 2, 3, or 4 Cardiac ischemia/infarction","longName":"2571522","preferredDefinition":"Grade 2, 3, or 4 Cardiac ischemia/infarction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E46F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B79B8-7A28-114A-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 CNS cerebrovascular ischemia","valueDescription":"Grade 2, 3, or 4 CNS cerebrovascular ischemia","ValueMeaning":{"publicId":"2571523","version":"1","preferredName":"Grade 2, 3, or 4 CNS cerebrovascular ischemia","longName":"2571523","preferredDefinition":"Grade 2, 3, or 4 CNS cerebrovascular ischemia","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E470-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B6FFD-3BED-1064-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 1, 2, 3, or 4 GI perforation, GI leak, or GI fistula","valueDescription":"Grade 1, 2, 3, or 4 GI perforation, GI leak, or GI fistula","ValueMeaning":{"publicId":"2571524","version":"1","preferredName":"Grade 1, 2, 3, or 4 GI perforation, GI leak, or GI fistula","longName":"2571524","preferredDefinition":"Grade 1, 2, 3, or 4 GI perforation, GI leak, or GI fistula","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E471-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B6FFD-3BF1-1064-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 4 Intra-abdominal abscess/Infection","valueDescription":"Grade 4 Intra-abdominal abscess/Infection","ValueMeaning":{"publicId":"2571525","version":"1","preferredName":"Grade 4 Intra-abdominal abscess/Infection","longName":"2571525","preferredDefinition":"Grade 4 Intra-abdominal abscess/Infection","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E472-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B6FFD-3BF5-1064-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 Wound complication, non-infectious","valueDescription":"Grade 2, 3, or 4 Wound complication, non-infectious","ValueMeaning":{"publicId":"2571526","version":"1","preferredName":"Grade 2, 3, or 4 Wound complication, non-infectious","longName":"2571526","preferredDefinition":"Grade 2, 3, or 4 Wound complication, non-infectious","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E473-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B6FFD-3BF9-1064-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 4 Proteinuria","valueDescription":"Grade 4 Proteinuria","ValueMeaning":{"publicId":"2571527","version":"1","preferredName":"Grade 4 Proteinuria","longName":"2571527","preferredDefinition":"Grade 4 Proteinuria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E474-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17B6FFD-3BFD-1064-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 4 Hypertension","valueDescription":"Grade 4 Hypertension","ValueMeaning":{"publicId":"2571528","version":"1","preferredName":"Grade 4 Hypertension","longName":"2571528","preferredDefinition":"Grade 4 Hypertension","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E475-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17AB3CA-C3D4-1148-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Other clinically significant Grade 4 AE related to Bevacizumab","valueDescription":"Other clinically significant Grade 4 AE related to Bevacizumab","ValueMeaning":{"publicId":"2571529","version":"1","preferredName":"Other clinically significant Grade 4 AE related to Bevacizumab","longName":"2571529","preferredDefinition":"Other clinically significant Grade 4 AE related to Bevacizumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E476-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17AB3CA-C3D8-1148-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Grade 4 Thrombosis/Thrombus/Embolism","valueDescription":"Grade 4 Thrombosis/Thrombus/Embolism","ValueMeaning":{"publicId":"2571530","version":"1","preferredName":"Grade 4 Thrombosis/Thrombus/Embolism","longName":"2571530","preferredDefinition":"Grade 4 Thrombosis/Thrombus/Embolism","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E477-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"CAMPBELB","dateModified":"2004-08-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E17AB6D5-53F5-114E-E034-0003BA12F5E7","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E17B6FFD-3BD6-1064-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-12","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Adverse events which require","type":"Preferred Question Text","description":"Adverse events which require discontinuation of bevacizumab","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E8BCE09-1BA6-3C2D-E053-F662850A48C1","latestVersionIndicator":"Yes","beginDate":"2004-08-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-06-13","modifiedBy":"HARTLEYG","dateModified":"2018-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}